Analysis of the Level of IgG to SARS-CoV-2 Virus and Molecular Markers of Activation of CD25, CD54 (ICAM-1) and CD95 Lymphocytes in the Patients Who were Not Ill with COVID-19, Recovered from COVID-19 and Who had Acute Respiratory Infections. The Results of the Correction of Impaired Immune Homeostasis Using the Multitarget Immunotherapy Drug Mercureid | Zendy

AI Assistant Blog Pricing

Open Access

Analysis of the Level of IgG to SARS-CoV-2 Virus and Molecular Markers of Activation of CD25, CD54 (ICAM-1) and CD95 Lymphocytes in the Patients Who were Not Ill with COVID-19, Recovered from COVID-19 and Who had Acute Respiratory Infections. The Results of the Correction of Impaired Immune Homeostasis Using the Multitarget Immunotherapy Drug Mercureid

Author(s) -

Gusev SN

Publication year - 2022

Language(s) - English

DOI - 10.46889/jcim.2022.3304

Subject(s) - immunology , asymptomatic , antibody , virus , immune system , medicine , virology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

Discover

Explore

Copyright Knowledge E © 2025. All Rights Reserved.